Search research articles
Contact Us
Filters
Showing results (201-210 of 213) with videos related to
Page
of 22
Sort By:
Dermatologic Therapy
|
October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study
Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
International Journal of Dermatology
|
May 24, 2022
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach
Clara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
Frontiers in Medicine
|
August 24, 2023
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba, et al.
Dermatology and Therapy
|
January 11, 2021
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, et al.
Clinical Drug Investigation
|
May 15, 2025
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)
Maria Esposito, Paolo Gisondi, Chiara Assorgi, et al.
Allergy
|
June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Andrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Dermatology Practical & Conceptual
|
February 28, 2024
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Piergiorgio Malagoli, Anna Balato, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Andrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study
Riccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 213) with videos related to
Sort By:
Page
of 22
Dermatologic Therapy
|
October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study
Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
International Journal of Dermatology
|
May 24, 2022
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach
Clara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
Frontiers in Medicine
|
August 24, 2023
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba, et al.
Dermatology and Therapy
|
January 11, 2021
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, et al.
Clinical Drug Investigation
|
May 15, 2025
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)
Maria Esposito, Paolo Gisondi, Chiara Assorgi, et al.
Allergy
|
June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Andrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Dermatology Practical & Conceptual
|
February 28, 2024
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Piergiorgio Malagoli, Anna Balato, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Andrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study
Riccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Page
of 22